DA 7911

Drug Profile

DA 7911

Alternative Names: 188Re-tin-colloid; DA-7911

Latest Information Update: 14 Jun 2010

Price : $50

At a glance

  • Originator Dong-A Pharmaceutical
  • Class Antirheumatics; Heavy metals; Radiopharmaceuticals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 28 Oct 2004 Clinical trials in Rheumatoid arthritis in South Korea (Intra-articular)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top